Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | PDIA6 | Q15084 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14849958 | 0.84 | ALDH1A1 (0.42) | ALDH1A1LMNAKDM4EGAAHPGD | |
| SCHEMBL2293276 | 0.80 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL2288088 | 0.79 | MEN1 (0.43) | ALDH1A1LMNAGAAHPGD | |
| SCHEMBL2289720 | 0.77 | THRA (0.35) | ALDH1A1LMNA | |
| SCHEMBL2289174 | 0.77 | ALDH1A1 (0.39) | ALDH1A1LMNAHPGD | |
| SCHEMBL2296280 | 0.75 | ALDH1A1 (0.41) | ALDH1A1LMNAKDM4EGAAHPGD | |
| SCHEMBL203680 | 0.75 | ALDH1A1 (0.43) | ALDH1A1LMNAKDM4EGAAHPGD | |
| SCHEMBL20582868 | 0.74 | ALDH1A1 (0.44) | ALDH1A1LMNAKDM4EGAAHPGD | |
| SCHEMBL29497677 | 0.74 | ALDH1A1 (0.44) | ALDH1A1LMNAKDM4EGAAHPGD | |
| SCHEMBL6901293 | 0.73 | ALDH1A1 (0.41) | ALDH1A1KDM4EGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2149545-B1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2016-10-05 | — | — | EP | disclosed |
| US-7994367-B2 | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-08-19 | — | — | US | disclosed |
| EP-2149545-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | NQO1, C9, TRPA1 | ALDH1A1 83/4885LMNA 1225/4885KDM4E 1499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.